- ►shouxi.net C Werner, CH Kamani, C Gensch, M Böhm, U … - Diabetes, 2007 - Am Diabetes Assoc Peroxisome proliferator–activated receptor-γ (PPARγ) agonists
(thiazolidinediones [TZDs]) lower serum glucose levels in patients with type 2
diabetes (1). In addition to their insulin-sensitizing effects, increasing ... Cited by 38 - Related articles - BL Direct - All 4 versions
C Gensch, YP Clever, C Werner, M Hanhoun, … - Atherosclerosis, 2007 - Elsevier PPAR-γ agonists (thiazolidinediones, TZDs) may improve endothelial function
independently of insulin sensitizing. Bone marrow-derived endothelial progenitor
cells (EPC) contribute to neoangiogenesis. Mice were treated with ... Cited by 65 - Related articles - All 11 versions
CH Wang, MK Ting, S Verma, LT Kuo, NI Yang … - American heart journal, 2006 - Elsevier After pioglitazone treatment, the numbers of circulating EPCs significantly
increased (from 0.44% ± 0.14% to 0.89% ± 0.29%, P = .01). The migratory
response and the adhesive capacity to fibronectin and collagen were ... Cited by 53 - Related articles - All 14 versions
S REDONDO, M HRISTOV, D GÜMBEL, T … - Thrombosis and haemostasis, 2007 - cat.inist.fr Endothelial progenitor cells(EPCs) have been implicated in vascular repair and
found to be functionally impaired in patients with diabetes. We evaluated the
effects of the anti-diabetic drug pioglitazone on human EPC function and ... Cited by 15 - Related articles - BL Direct - All 2 versions
F Pistrosch, K Herbrig, U Oelschlaegel, S … - Atherosclerosis, 2005 - Elsevier We investigated 10 recently diagnosed type 2 diabetic patients and 10 age and
sex matched healthy control subjects. After baseline examination of metabolic
parameters and EPC, patients received 4 mg rosiglitazone bid for 12 weeks. ... Cited by 97 - Related articles - All 12 versions
F Biscetti, E Gaetani, A Flex, T Aprahamian, T … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Activation of PPARα and PPARγ leads to endothelial tube formation in
an endothelial/interstitial cell co-culture assay. This effect is associated
with increased production of the angiogenic cytokine vascular endothelial ... Cited by 18 - Related articles - BL Direct - All 3 versions
- ►jbc.org KY Kim, HG Cheon - Journal of Biological Chemistry, 2006 - ASBMB Recent evidence shows that peroxisome proliferator-activated receptor (PPAR )
ligands induce the antiangiogenic effect in endothelial cells and tumors. In the
present study, we elucidated the involvement of maxi-K channel activation ... Cited by 16 - Related articles - BL Direct - All 6 versions
B Xin, Y Yokoyama, T Shigeto, M Futagami, … - CA A Cancer Journal for Clinicians - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 20 - Related articles - All 3 versions
- ►ahajournals.org CH Wang, N Ciliberti, SH Li, PE Szmitko, RD … - Circulation, 2004 - Am Heart Assoc Methods and Results— C57/BL6 mice, treated with or without rosiglitazone (8
mg/kg per day), a PPAR- agonist, underwent femoral angioplasty. Rosiglitazone
treatment attenuated neointimal formation (intima/media ratio: 0.98±0.12 [ ... Cited by 126 - Related articles - BL Direct - All 9 versions
- ►nih.gov R Shibata, C Skurk, N Ouchi, G Galasso, K … - FEBS letters, 2008 - Elsevier Obesity-linked diseases are associated with suppressed endothelial progenitor
cell (EPC) function. Adiponectin is an adipose-derived protein that is
downregulated in obese and diabetic subjects. Here, we investigated the ... Cited by 11 - Related articles - All 5 versions
